3-Dimensional Computed Tomography Lymphography–Guided Identification of Sentinel Lymph Nodes in Breast Cancer Patients Using Subcutaneous Injection of Nonionic Contrast Medium
- 1 January 2004
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 28 (1) , 46-51
- https://doi.org/10.1097/00004728-200401000-00007
Abstract
Simple and reliable identification methods for sentinel lymph nodes (SLNs) which do not use radioisotope are essential for early breast cancer patients in community hospitals in Japan. The purpose of this paper is to demonstrate the feasibility and efficacy of computed tomography (CT) lymphography for SLN detection. The study included 15 cases with T1 or T2 breast cancer. After subcutaneous injection of 1 mL of iopamidol in 1 subareolar area of the affected breast, CT scanning was carried out and 3-dimensional (3D) CT images were created. SLNs predicted from images and CT values were assessed as to whether they were identical to those identified by the dye method. An enhanced lymph vessel draining into SLN was demonstrated in 11 cases (73%) and an enhanced SLN in 10 cases (67%). 3D images clearly revealed the anatomic relationship between lymph vessels, SLN, and the surrounding structures. In addition, SLN could be predicted by the change of CT value in the time-course in another case. In total, SLN in 13 cases (87%) could be predicted. All SLNs suggested from CT lymphography were identified by the dye method. No significant adverse effect was noted in any case. The present clinical trial indicated that subcutaneous injection of nonionic contrast medium with CT scanning seems to be a promising method for the demonstration of a draining lymph vessel and SLN. The CT value time-course may also provide some important information. Further trials will be needed for the successful establishment of this CT lymphography-guided method for SLN identification.Keywords
This publication has 23 references indexed in Scilit:
- Sentinel lymph node dissection in early stage breast cancerBreast Cancer, 2002
- Sentinel node biopsy to avoid axillary lymph node dissection in breast cancer.Breast Cancer, 2002
- Effect of the use of vital dye, lymphoscintigraphy, or a combination for axillary lymphatic mapping and sentinel node biopsy in breast cancerWorld Journal of Surgery, 2002
- Combination technique is superior to dye alone in identification of the sentinel node in breast cancer patientsJournal of Surgical Oncology, 2001
- Multicenter Trial of Sentinel Node Biopsy for Breast Cancer Using Both Technetium Sulfur Colloid and Isosulfan Blue DyeAnnals of Surgery, 2001
- Guidelines for Sentinel Node Biopsy and Lymphatic Mapping of Patients With Breast CancerAnnals of Surgery, 1998
- Sentinel Lymph Node Biopsy in Breast Cancer: Guidelines and Pitfalls of Lymphoscintigraphy and Gamma Probe DetectionJournal of the American College of Surgeons, 1998
- Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodesThe Lancet, 1997
- Guest editorial: Sentinel lymphadenectomy in primary breast carcinoma: An alternative to routine axillary dissectionJournal of Surgical Oncology, 1996
- Lymphatic Mapping and Sentinel Lymphadenectomy for Breast CancerAnnals of Surgery, 1994